- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Energy
Daily Deal Round Up: June 22, 2022
Illumina and Celgene could exit genome researcher Human Longevity in a reverse merger while Openly raised $75m from investors including Advance Venture Partners and Gradient Ventures.
Jun 22, 2022Here's what a typical CVC unit looks like
Asian, fintech-focused and less than seven years old – some of the CVC trends we saw when compiling the Global Corporate Venturing Directory.
Jun 22, 2022Daily Deal Round Up: June 15, 2022
GV took part in food delivery service Wonder Group’s $350m series B round while two Hanwha subsidiaries contributed to a $145m round for eVTOL aircraft developer Overair.
Jun 15, 2022CVC case study: Prologis Ventures' lean team
The 10-person team at Prologis Ventures is on the smaller end of the scale but has made 37 investments over the past six years.
Jun 15, 2022CVC case study: Saint-Gobain NOVA is organised by geography
Each team member will do every part of the process, from scouting, selection to presenting ideas to the business units.
Jun 15, 2022CVC case study: How TDK Ventures' young team grew
TDK Ventures started with a minimal team size while it was proving itself and grew it when the portfolio needed more support.
Jun 15, 2022CVC case study: Capita Scaling Partner's equity-for-services model
Capita Scaling Partner's equity-for-services model needs a team of 28, most focusing on finding synergies between the parent and the startup.
Jun 15, 2022What is the ideal size for a CVC team?
The short answer is: “It depends” (on strategy, focus and structure). A quick rule of thumb is 3 people per $100m in the fund.
Jun 15, 2022Deeptech Labs unveils six for spring cohort
The Arm-backed accelerator picked six companies for its largest cohort yet, focusing on hardware, manufacturing and knowledge.
Jun 14, 2022Daily Deal Round Up: June 9, 2022
GV participated in tech apprenticeship platform Multiverse’s $220m series D round while Amgen, UCB, UPMC and Takeda helped genetics disease drug developer Code Biotherapeutics raise $75m.
Jun 9, 2022Australian investors in 'significant pullback'
GCV has spoken to several corporate and VC investors about the recent hit to Australia's startup scene following a post-lockdown deal surge.
Jun 9, 2022Severstal to terminate its corporate venturing unit
The Russia-based steelmaker’s Severstal Ventures unit is shutting down amid geopolitical crisis-induced sanctions.
Jun 9, 2022Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


